ATE170873T1 - Bombesin-analogen - Google Patents
Bombesin-analogenInfo
- Publication number
- ATE170873T1 ATE170873T1 AT95301627T AT95301627T ATE170873T1 AT E170873 T1 ATE170873 T1 AT E170873T1 AT 95301627 T AT95301627 T AT 95301627T AT 95301627 T AT95301627 T AT 95301627T AT E170873 T1 ATE170873 T1 AT E170873T1
- Authority
- AT
- Austria
- Prior art keywords
- alpha
- nle
- ile
- phe
- leu
- Prior art date
Links
- QXZBMSIDSOZZHK-DOPDSADYSA-N 31362-50-2 Chemical class C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(N)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H]1NC(=O)CC1)C(C)C)C1=CNC=N1 QXZBMSIDSOZZHK-DOPDSADYSA-N 0.000 title 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N 2-Aminobutanoic acid Natural products CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 abstract 4
- QWCKQJZIFLGMSD-GSVOUGTGSA-N D-alpha-aminobutyric acid Chemical compound CC[C@@H](N)C(O)=O QWCKQJZIFLGMSD-GSVOUGTGSA-N 0.000 abstract 4
- 101000909637 Homo sapiens Transcription factor COE1 Proteins 0.000 abstract 2
- 102100024207 Transcription factor COE1 Human genes 0.000 abstract 2
- 125000003884 phenylalkyl group Chemical group 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 125000004642 (C1-C12) alkoxy group Chemical group 0.000 abstract 1
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 abstract 1
- 125000003837 (C1-C20) alkyl group Chemical group 0.000 abstract 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 abstract 1
- 125000001624 naphthyl group Chemical group 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002071 phenylalkoxy group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
- C07K7/086—Bombesin; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Compounds Of Unknown Constitution (AREA)
- Silicon Polymers (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP95301627A EP0737691B1 (de) | 1995-03-13 | 1995-03-13 | Bombesin-Analogen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE170873T1 true ATE170873T1 (de) | 1998-09-15 |
Family
ID=8221124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT95301627T ATE170873T1 (de) | 1995-03-13 | 1995-03-13 | Bombesin-analogen |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0737691B1 (de) |
| AT (1) | ATE170873T1 (de) |
| DE (1) | DE69504634T2 (de) |
| DK (1) | DK0737691T3 (de) |
| ES (1) | ES2124496T3 (de) |
| SI (1) | SI0737691T1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2726092A1 (en) | 2008-06-12 | 2009-12-17 | Syntaxin Limited | Suppression of cancers |
| EP2719392B1 (de) | 2008-06-12 | 2019-07-24 | Ipsen Bioinnovation Limited | Fusionproteine zur Verwendung bei der Behandlung von Akromegalie |
| GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05506862A (ja) * | 1990-05-09 | 1993-10-07 | ジ・アドミニストレイターズ・オブ・ザ・トゥーラン・エデュケイショナル・ファンド | 環状および鎖状の治療用ペプチド |
-
1995
- 1995-03-13 EP EP95301627A patent/EP0737691B1/de not_active Expired - Lifetime
- 1995-03-13 DE DE69504634T patent/DE69504634T2/de not_active Expired - Fee Related
- 1995-03-13 ES ES95301627T patent/ES2124496T3/es not_active Expired - Lifetime
- 1995-03-13 AT AT95301627T patent/ATE170873T1/de not_active IP Right Cessation
- 1995-03-13 DK DK95301627T patent/DK0737691T3/da active
- 1995-03-13 SI SI9530167T patent/SI0737691T1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0737691A1 (de) | 1996-10-16 |
| SI0737691T1 (en) | 1998-12-31 |
| HK1016416A1 (en) | 1999-10-29 |
| DE69504634D1 (de) | 1998-10-15 |
| ES2124496T3 (es) | 1999-02-01 |
| DK0737691T3 (da) | 1999-06-07 |
| EP0737691B1 (de) | 1998-09-09 |
| DE69504634T2 (de) | 1999-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE266043T1 (de) | Peptidanaloge des menschlichen basischen myelinproteins | |
| DE69332826T2 (de) | Opioidpeptide | |
| HUP0000492A1 (hu) | N-(Aril/heteroaril-acetil)-aminosav-észterek, azokat tartalmazó gyógyászati készítmények, valamint módszerek béta-amiloid fehérje képződése és felszabadulása gátlására e vegyületek felhasználásával | |
| HUP0301842A2 (hu) | Laktám vegyület, a vegyületet tartalmazó gyógyszerkészítmény és alkalmazása gyógyszerkészítmény elżállítására | |
| HUP0300684A2 (hu) | Szomatosztatin analógok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| BR9714358A (pt) | Derivados de n- (arila/heteroarila) amino ácido,composições farmacêuticas compreendendo os mesmos, e métodos para a inibição de liberação de peptìdeo beta-amilóide e/ou sua sìntese por uso de tais compostos | |
| MA22476A1 (fr) | Bis-naphtalimides contenant des linkers derives d'acides amines comme agents anti-cancer | |
| FI943235A0 (fi) | Uusi ihmisen Kunitz-tyyppinen proteaasiestäjä ja sen muunnnoksia | |
| TR199501630A2 (tr) | Peptid p277 benzerleri ve diagnoz ve dibetlerin'lerin tedavisi icin onlari iceren kompozisyonlar. | |
| ATE121755T1 (de) | Deletionsanaloga von magaininpeptiden. | |
| SE9300012D0 (sv) | New peptides | |
| WO1996028470A3 (en) | Peptide analogues of human myelin basic protein useful in treating multiple sclerosis | |
| CY1107990T1 (el) | Τριπεπτιδια και παραγωγα τριπεπτιδιων για τη θepαπεια νευροεκφυλιστικων ασθενειων | |
| DE69012901D1 (de) | Hämoregulierende Peptide. | |
| MY124560A (en) | Amino acid compositions and use thereof in immunosuppression | |
| ATE170873T1 (de) | Bombesin-analogen | |
| DK0703923T3 (da) | Faktor VII afledte peptider | |
| ATE125548T1 (de) | Peptide. | |
| HUP9602024A2 (hu) | Aminosavtartalmú, külsőlegesen használható, gyógyhatású készítmény | |
| DE69312322D1 (de) | Cephem verbindungen mit antimicrobizide eigenschaften | |
| TH4141A (th) | สารคล้ายคลึง จีอาร์เอฟ (grf) | |
| TH35998A (th) | Lh-rh เป็ปไทด์ อะนาล็อก ประโยชน์ของสิ่งเหล่านั้นและองค์ประกอบทางเภสัชกรรมซึ่งประกอบด้วยสิ่งเหล่านั้น | |
| ECSP972344A (es) | Proteinas antiobesidad |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEIH | Change in the person of patent owner | ||
| REN | Ceased due to non-payment of the annual fee |